Trademarkia Logo

Canada

C$
Trademark Search in Canada
CASEBIA THERAPEUTICS & DESIGN

View On IC.GC.CA

CASEBIA THERAPEUTICS & DESIGN
REGISTERED

on 13 Aug 2019

Last Applicant/ Owned by

CASEBIA THERAPEUTICS LIMITED LIABILITY PARTNERSHIP

c/o Jacksons AccountantsThe Old Bakehouse, Course RoadAscotBerkshire SL57HL

GB

Serial Number

1849450 filed on 26th Jul 2017

Registration Number

TMA1048796 registered on 13th Aug 2019

Registration expiry Date

13th Aug 2029

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

CASEBIA THERAPEUTICS & DESIGN

Trademark usage description

gene therapy products, namely, therapeutic preparations for the treatment of hepatological, namely, liver, gallbladder, and pancreas diseases and diso Read More

Vienna Information

26 . 7 . 5

Circles or ellipses with one or more other quadrilateralsCercles ou ellipses avec un ou plusieurs quadrilatères

26 . 7 . 7

Circle or ellipses with one or more other polygonsCercles ou ellipses avec un ou plusieurs autres polygones

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 5 . 1

One polygonUn polygone

Classification Information

Class [005]
Gene therapy products, namely, therapeutic preparations for the treatment of hepatological, namely, liver, gallbladder, and pancreas diseases and disorders, cardiovascular, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases, endocrine, gastrointestinal, immunological, namely, autoimmune diseases and immunologic deficiency syndromes, dermatological, namely, dermatitis, skin pigmentation diseases, eczema and psoriasis, infectious, namely respiratory infections, eye infections and topical infections, inflammatory, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, menopausal, metabolic, namely, diabetes, hypoglycaemia, gout and anorexia, autoimmune, musculoskeletal, neurological, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease and cerebral palsy, ophthalmologic, psychiatric, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders, namely, herpes and hepatitis

Classification kind code

11

Class [042]
Research and development of human therapeutics using gene editing; pharmaceutical research and development services

Classification kind code

11

Mark Details

Serial Number

1849450

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 7th Aug 2019		Registration Pending
Submitted for opposition 42
on 15th May 2019		Advertised
Submitted for opposition 26
on 23rd Apr 2019		Approved
Submitted for opposition 130
on 3rd Apr 2019		Note to file
Submitted for opposition 27
on 8th Mar 2019		Approval Notice Sent
Submitted for opposition 22
on 20th Aug 2018		Search Recorded
Submitted for opposition 20
on 20th Aug 2018		Examiner's First Report
Submitted for opposition 31
on 31st Jul 2017		Formalized
Submitted for opposition 1
on 27th Jul 2017		Created
Submitted for opposition 30
on 26th Jul 2017		Filed